Tiago Fauth

Stock Analyst at Wells Fargo

(0)
# 4832
Out of 5,335 analysts
165
Total ratings
25.96%
Success rate
-24.07%
Average return
44 Stocks
Name Action PT Current % Upside Ratings Updated
VRNA Verona Pharma
Maintains: Overweight
93 107
67.81 57.79% 5 Apr 30, 2025
UTHR United Therapeutics
Downgrades: Equal-Weight
395 314
307.2 2.21% 5 Apr 25, 2025
TECX Tectonic Therapeutic
Maintains: Overweight
112 101
20 405% 4 Mar 21, 2025
ALNY Alnylam Pharmaceutic...
Maintains: Equal-Weight
275 287
265.96 7.91% 5 Mar 21, 2025
PLRX Pliant Therapeutics
Maintains: Equal-Weight
4 3
1.37 118.98% 2 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
28 26
13.39 94.17% 6 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
18 17
6.07 180.07% 1 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
85 107
66.37 61.22% 3 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
14 11
1.09 909.17% 2 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
75 88
35.34 149.01% 7 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
8
2.93 173.04% 1 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
9
4.68 92.31% 1 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
56 68
46.05 47.67% 1 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
11 22
6.42 242.68% 2 Oct 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
75
46.12 62.62% 1 Aug 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
1225 70
n/a n/a 2 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
63 62
1.24 4900% 5 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
89
159.22 -44.1% 16 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
51
12.65 303.16% 3 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
120
59.91 100.3% 7 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
120
n/a n/a 6 May 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
4
14.11 -71.65% 4 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
22 17
n/a n/a 2 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
14
2.92 379.45% 4 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
4
0.06 6566.67% 5 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
26
5.79 349.05% 5 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 28
2.05 1265.85% 7 May 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
70 81
17.38 366.05% 11 May 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
139 200
n/a n/a 5 Apr 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
1
n/a n/a 3 Apr 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
8
0.42 1804.76% 5 Mar 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
14
1.15 1117.39% 2 Mar 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
38 34
0.46 7291.3% 2 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
150
2.76 5334.78% 2 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
29
36.87 -21.35% 1 Jan 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
13
1.36 855.88% 1 Dec 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 13
1.49 772.48% 2 Nov 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20
n/a n/a 3 Sep 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
3 2
1.74 14.94% 4 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
297 340
541.43 -37.2% 3 Dec 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 18
n/a n/a 2 Sep 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
102 98
n/a n/a 1 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
265 259
272.14 -4.83% 1 Apr 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
60 42
n/a n/a 5 Nov 10, 2020